UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HIV/AIDS Vaccines: 2018

Clinical pharmacology and therapeutics, 2018-12, Vol.104 (6), p.1062-1073

Robinson, Harriet L.

2018

Volltextzugriff (PDF)

A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model

Scientific reports, 2017-11, Vol.7 (1), p.14769-11, Article 14769

2017

Volltextzugriff (PDF)

Multiple-Cytokine-Producing Antiviral CD4 T Cells Are Functionally Superior to Single-Cytokine-Producing Cells

Journal of Virology, 2007-08, Vol.81 (16), p.8468-8476

2007

Volltextzugriff (PDF)

Non-neutralizing antibodies in prevention of HIV infection

Expert opinion on biological therapy, 2013-02, Vol.13 (2), p.197-207

Robinson, Harriet L.

2013

Volltextzugriff (PDF)

DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus

PloS one, 2016-10, Vol.11 (10), p.e0163164

2016

Volltextzugriff (PDF)

HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site

PloS one, 2017-10, Vol.12 (10), p.e0177863-e0177863

2017

Volltextzugriff (PDF)

One Group's Historical Reflections on DNA Vaccine Development

Human gene therapy, 2018-09, Vol.29 (9), p.966-970

2018

Volltextzugriff (PDF)

A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge

Scientific reports, 2018-01, Vol.8 (1), p.864-9, Article 864

2018

Volltextzugriff (PDF)

Ebola virus - prospects for a novel virus-like-particle-expressing modified vaccinia Ankara-based vaccine

Expert review of vaccines, 2018-09, Vol.17 (9), p.769-771

2018

Volltextzugriff (PDF)

CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge

Journal of virology, 2014-09, Vol.88 (17), p.9579-9589

2014

Volltextzugriff (PDF)

Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses

Proceedings of the National Academy of Sciences - PNAS, 2015-08, Vol.112 (34), p.10780-10785

2015

Volltextzugriff (PDF)

DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge

Proceedings of the National Academy of Sciences - PNAS, 2013-02, Vol.110 (8), p.2975-2980

2013

Volltextzugriff (PDF)

T cell vaccines for microbial infections

Nature medicine, 2005-04, Vol.11 (4 Suppl), p.S25-S32

2005

Volltextzugriff (PDF)

Human Immunodeficiency Virus Type 1 Controllers but Not Noncontrollers Maintain CD4 T Cells Coexpressing Three Cytokines

Journal of Virology, 2007-11, Vol.81 (21), p.12071-12076

2007

Volltextzugriff (PDF)

Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles

The Journal of infectious diseases, 2011-03, Vol.203 (5), p.610-619

2011

Volltextzugriff (PDF)

HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine

Journal of virology, 2017-12, Vol.91 (24)

2017

Volltextzugriff (PDF)

Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles

The Journal of infectious diseases, 2014-07, Vol.210 (1), p.99-110

2014

Volltextzugriff (PDF)

Prevention of Infection by a Granulocyte-Macrophage Colony-Stimulating Factor Co-Expressing DNA/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine

The Journal of infectious diseases, 2011-07, Vol.204 (1), p.164-173

2011

Volltextzugriff (PDF)

Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature

Scientific reports, 2020-08, Vol.10 (1), p.13031, Article 13031

2020

Volltextzugriff (PDF)

Protective immunity from a germinal center sanctuary

Nature medicine, 2012-11, Vol.18 (11), p.1614-1616

2012

Volltextzugriff (PDF)

New hope for an aids vaccine

Nature reviews. Immunology, 2002-04, Vol.2 (4), p.239-250

Robinson, Harriet L

2002

Volltextzugriff (PDF)

Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus

The Journal of experimental medicine, 2007-10, Vol.204 (11), p.2733-2746

2007

Volltextzugriff (PDF)

Preclinical Studies of Human Immunodeficiency Virus/AIDS Vaccines: Inverse Correlation between Avidity of Anti-Env Antibodies and Peak Postchallenge Viremia

Journal of Virology, 2009-05, Vol.83 (9), p.4102-4111

2009

Volltextzugriff (PDF)

1 – 25 von 382

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(292)
Mit Volltextzugriff
(331)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(382)

Erscheinungsjahr

n.n

Thema

Science & Technology
(200)
Life Sciences & Biomedicine
(184)
Animals
(130)
Humans
(119)
Virology
(82)
Biological And Medical Sciences
(60)
Female
(60)
Immunology
(59)
Vaccines, Dna - Immunology
(59)
Microbiology
(53)
Fundamental And Applied Biological Sciences. Psychology
(44)
Macaca Mulatta
(40)
Male
(39)
Aids Vaccines - Immunology
(38)
Mice
(37)
Infectious Diseases
(34)
Vaccination
(34)
Dna
(33)
Vaccines
(33)
Medical Sciences
(32)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Virology
(29)
Virology
(25)
British Journal Of Psychiatry
(17)
Aids Research And Human Retroviruses
(16)
Vaccine
(16)
Time
(13)
The Journal Of Infectious Diseases
(10)
Investors Chronicle
(9)
The Woman's Tribune
(9)
The journal Of Infectious Diseases
(9)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

HIV/AIDS Vaccines: 2018

A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model

Multiple-Cytokine-Producing Antiviral CD4 T Cells Are Functionally Superior to Single-Cytokine-Producing Cells

Non-neutralizing antibodies in prevention of HIV infection

DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus

HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site

One Group's Historical Reflections on DNA Vaccine Development

A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge

Ebola virus - prospects for a novel virus-like-particle-expressing modified vaccinia Ankara-based vaccine

CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge

Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses

Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults

DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge

T cell vaccines for microbial infections

Human Immunodeficiency Virus Type 1 Controllers but Not Noncontrollers Maintain CD4 T Cells Coexpressing Three Cytokines

Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles

HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine

AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period

Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles

Prevention of Infection by a Granulocyte-Macrophage Colony-Stimulating Factor Co-Expressing DNA/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine

Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature

Protective immunity from a germinal center sanctuary

New hope for an aids vaccine

Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus

Preclinical Studies of Human Immunodeficiency Virus/AIDS Vaccines: Inverse Correlation between Avidity of Anti-Env Antibodies and Peak Postchallenge Viremia

Suchergebnisse filtern